Application of dsRNA based on LCP22 gene in prevention and control of boettcherisca peregrina

Through RNA interference technology, the dsRNA of the LCP22 gene of the brown-tailed pest control measures have solved the problem of the great impact and poor effect on the environment and non-target organisms, and the survival rate and reproductive ability of the brown-tailed pest control measures have been significantly reduced. The effect of this paper provides scientific basis and potential targets for public health strategies.

CN118910068APending Publication Date: 2024-11-08CENT SOUTH UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410800244.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-06-20
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

Existing pest control measures are difficult to effectively control the survival and reproduction of brown-tailed erectile dysfunction flies, and traditional methods have a great impact on the environment and non-target organisms, and lack scientific basis for environmental protection.

Method used

Using RNA interference technology, dsRNA targeting the LCP22 gene of the brown-tailed erectile dysfunction is synthesized in vitro, interfering with its expression, resulting in larval metamorphosis, pupal shell deformity and adult wing defects, significantly reducing pupation and feathering rate, thereby weakening its survival and reproduction. ability.

Benefits of technology

Through RNAi interference, the survival rate and reproductive ability of brown-tailed erectile dysfunction flies is significantly reduced, providing an environmentally friendly pest control method, and providing scientific basis and potential targets for public health strategies.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118910068A_ABST
    Figure CN118910068A_ABST
Patent Text Reader

Abstract

The invention provides application of dsRNA based on an LCP22 gene in prevention and control of boettcherisca peregrina for the first time, and belongs to the field of genetic engineering technology and pest prevention and control. According to the present invention, the RNA interference (RNAi) technology is firstly utilized to target the LCP22 gene (SPLCP22) of the boettcherisca peregrina, the SPLCP22 gene is interfered by using the in-vitro synthesized double-stranded RNA (dsRNA), and it is observed that compared with the control group, the phenotypes such as pupa and adult development malformation, significant reduction of pupation rate and eclosion rate and the like appear during the metamorphosis development process of the boettcherisca peregrina interfered by the dsRNA; the RNAi interference also leads to the significant reduction of the expression of other growth and development related genes, which shows that the dsRNA based on the LCP22 gene can effectively kill the boettcherisca peregrina and significantly reduce the survival rate of the boettcherisca peregrina, and has important significance in the prevention and control of the boettcherisca peregrina.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of genetic engineering, and in particular to an application of dsRNA based on LCP22 gene in the prevention and treatment of Sarcoptes chinensis. Background Art

[0002] Sarcophaga peregrina is a widely distributed pest in the world and is a public health pest. The development of targeted control measures is of great significance to public health. Sarcophaga peregrina (Diptera, Sarcophagidae) is widely distributed in the world and is especially common in temperate and tropical regions. Sarcophaga peregrina usually feeds on decaying organic matter such as carrion and animal carcasses, and therefore plays an important role as a decomposer in nature. It is also a key public health pest. It frequently acts as a disease transmitter in public health and animal husbandry, causing myiasis in humans and other mammals, especially livestock. The fly can also carry a variety of parasitic pathogens including bacteria, viruses and parasites, increasing its risk of acting as a disease carrier. Therefore, a comprehensive understanding of the role of Sarcophaga peregrina in disease transmission is essential for the development of public health strategies and the improvement of disease prevention measures. Developing targeted and effective control measures to reduce its breeding grounds and control its population is a key way to reduce its threat to public health.

[0003] RNA interference (RNAi) technology is a technology that inhibits the expression of specific genes through small fragments of RNA molecules. This technology uses the natural mechanism within the cell to trigger the silencing of specific genes by introducing double-stranded RNA (dsRNA), thereby inhibiting the expression of target genes. This method is widely used in gene function research, health prevention and control, pest control and other fields.

[0004] In the field of pest control, RNA interference technology introduces double-stranded RNA (dsRNA) to silence key genes of pests, inhibit their growth, development and reproduction, and thus effectively reduce the harm caused by pests. This technology can not only accurately control specific pest genes and reduce the impact on the environment and non-target organisms, but also provide a scientific basis for the development of new green pesticides, with broad application prospects and environmental advantages.

[0005] The LCP22 gene plays an important role in the formation of the insect exoskeleton, molting and development. It encodes long-chain cuticle proteins to build a hard and elastic exoskeleton and reshape the cuticle structure during molting. The expression of the LCP22 gene is regulated by developmental hormones to ensure the normal development of insects at different stages of their life cycle. Studying the LCP22 gene not only helps to reveal the molecular mechanism of insect development, but may also provide new gene targets for pest control.

[0006] By utilizing RNAi to interfere with the expression of the LCP22 gene (SP_LCP22) of the brown-tailed Sarcophagnum, its larval metamorphosis will be effectively caused to stagnate, the pupal shell is deformed or the pupal shell and the adult epidermis are closely adhered to each other, thereby causing the failure of pupation. In the adult in which the LCP22 gene is interfered, there will also be a wing defect phenotype, and the pupation rate and the eclosion rate are significantly reduced, etc., and the above changes ultimately cause the brown-tailed Sarcophagnum larvae to be blocked in the molting process, delayed growth and development, and reduced survival rate. These impacts significantly weaken the survival and reproductive capacity of the brown-tailed Sarcophagnum, significantly reduce the survival rate of the brown-tailed Sarcophagnum, and are of great significance in the control of the brown-tailed Sarcophagnum, and provide effective scientific basis and potential target for the brown-tailed Sarcophagnum pest control strategy based on RNAi. Therefore, the present invention adopts RNA interference technology, and the dsRNA molecular target for the LCP22 gene is relatively safe, which plays an important role in the control of the brown-tailed Sarcophagnum. Summary of the invention

[0007] The purpose of the present invention is to propose for the first time the application of dsRNA based on LCP22 gene in the control of brown-tailed flesh fly pests, which has a good pest control effect.

[0008] The technical solution of the present invention is achieved in this way:

[0009] The present invention provides for the first time a LCP22 gene (SP_LCP22) of Sarcoptes spp., whose nucleotide sequence is SEQ ID NO: 1 sequence.

[0010] The sequence is as follows:

[0011] ATGGGTTTTTGCATTGTATCCTTTCAGGCCAGTATTGCTTTGTGCAATGCCGCCCCAGCA

[0012] CCACAAAATGATGGCAAGTATCGTCCGCATGAAGATGGCAAATATCGTCCACGATCACAGAATG

[0013] AAGGGTCTATCATCATATGGTGCAGCCGTATGTGCATGTTCACGATAATCGTGAATTGGGCAA

[0014] ATAGTGCACGTACCAAATCCCTATGATGTGTGGTTATGGCCCTTATTCTGGTCTCAATTCACCC

[0015] TACATCCATGATGCACGTCCCTATGTACATGATGTCAAACCTTATGATCACAATTTGTACACAA

[0016] CCACAACTACAAAGAAACCAACCACAACTACAGAACGTACAACCACAACTACAACCACAACCAC

[0017] AACTACACCACGCAGCATTCTCTTCAACTATGATGATGAGGGCCGCCACAAAATTTTACATCAA

[0018] GAACATGACCGCAAACACGATAAATATGATCATGCTTACTTGACCGAGAATGGCATTTATGGCG

[0019] AAGAACAAGCTAAATTGCATCATACTGGGGGCACCCACGCCCAAGGTTACTATGAATACACCGG

[0020] TGACGATGGCAAATTGTATCGTGTCAACTACAAGAGTACCCATGAAGGTTTCATGCCTGAAGGT

[0021] GATCAATTCCCACACCACCACCAATTCCAGAAGCCATTGCTCGTGCCTTGAAATATGTCGATG

[0022] ACAAGCGTAAGGAGAATGGTGAAAAGCCCTTGTTCGATGAACGTGGCTTCCGTATTGATCACAT

[0023] GAGCAAGGATATGGTCAAGTCCATCAAATCTTTCACATTGAAGATATGCCCAAAGATATTGCT

[0024] GAACAAATACACGAATTGCAACTGGAAATGGATGCCCTCTACGGTCCAGATGATAATGATTATT

[0025] ATTAA.

[0026] The present invention further provides for the first time a specific dsRNA (SEQ ID NO: 2 and SEQ ID NO: 3) synthesized based on the SP_LCP22 gene fragment SEQ ID NO: 1 of the above-mentioned Sarcophaga rufipogonidae.

[0027] The present invention further provides the use of the dsRNA of the SP_LCP22 gene of the brown-tailed flesh fly in the control of the brown-tailed flesh fly.

[0028] The present invention further provides the use of the above-mentioned dsRNA of the SP_LCP22 gene of the brown-tailed flesh fly in the control of the brown-tailed flesh fly, characterized in that the dsRNA is prepared as a spray-type insecticide, or the dsRNA is prepared as a bait, or is directly injected into the body of the brown-tailed flesh fly.

[0029] The present invention has the following beneficial effects:

[0030] The present invention proposes for the first time an application of dsRNA based on the LCP22 gene in the control of brown-tailed flesh flies. For the first time, RNA interference (RNAi) technology is used to interfere with the LCP22 gene (SP_LCP22) of brown-tailed flesh flies through double-stranded RNA (dsRNA) synthesized in vitro. It is observed that compared with the control group, the brown-tailed flesh flies after dsRNA interference have phenotypes such as pupal and adult developmental deformities, and the pupation rate and eclosion rate are significantly reduced during the metamorphosis and development process. In addition, RNAi interference also leads to a significant decrease in the expression of other growth and development related genes (PCP1, LCP1, LCP2, LCP4). The above indicates that dsRNA based on the LCP22 gene can effectively kill brown-tailed flesh flies and significantly reduce the survival rate of brown-tailed flesh flies, which is of great significance in the control of brown-tailed flesh flies. This technological innovation provides a scientific basis and potential targets for the brown-tailed flesh fly pest control strategy based on RNAi, and provides a new way to control the population of brown-tailed flesh flies and reduce their threat to public health.

[0031] By collecting and analyzing samples of the brown-tailed flesh fly at different developmental stages, the present invention screened the brown-tailed flesh fly LCP22 gene (SP_LCP22) for the first time using high-throughput sequencing and bioinformatics analysis technology, and RT-qPCR showed the expression changes of the SP_LCP22 gene in the pupal stage. For the first time, RNA interference was performed on the SP_LCP22 gene, and the growth and development status of the brown-tailed flesh fly after RNA interference was observed, the interference efficiency of RNAi was verified, and the changes in other growth and development-related genes were analyzed. This study not only reveals the function of the LCP22 gene, but also provides a scientific basis and potential targets for the brown-tailed flesh fly pest management strategy based on RNAi, demonstrating a new and environmentally friendly pest control method with important practical value and application prospects. BRIEF DESCRIPTION OF THE DRAWINGS

[0032] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative labor.

[0033] Figure 1 The relative expression levels of SpLCP22 in different pupal stages of the brown-tailed flesh fly.

[0034] Figure 2 Results of RNAi experiments on the brown-tailed Sarcophaga, involving two dsRNA treatments: a control group of dsGFP and an experimental group of dsSpLCP22. Panel A: shows the change in pupation rate over time from the start of the experiment to 60 hours in the dsSpLCP22-treated group and the dsGFP control group. Panel B: summarizes the pupation rate at the end of the experiment in the form of a bar graph. Panel C: depicts the total development time of the two groups of samples in the pupal stage. Panel D: shows the comparison of the emergence rate.

[0035] Figure 3 The expression levels of different genes in the brown-tailed flesh fly after dsRNA treatment. Each sub-graph represents the relative expression level of different genes (SpLCP22, PCP1, LCP1, LCP2, LCP4) at two different time points (24 hours and 48 hours). The gray column represents the dsGFP control group, and the black column represents the dsSpLCP22 experimental group.

[0036] Figure 4 The effects of dsSpLCP22 and dsGFP on the morphology of the brown-tailed fly at different pupal stages. The figure shows samples of the early pupal stage, middle pupal stage, late pupal stage (after removing the pupal shell), and adult eclosion stage. DETAILED DESCRIPTION

[0037] The technical solutions in the embodiments of the present invention are described clearly and completely below. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0038] Example 1

[0039] 1. Collection and breeding of brown-tailed flies

[0040] Adults of the brown-tailed Sarcophaga were collected from dead animals in the wild, identified as the brown-tailed Sarcophaga by morphology, and then placed in an intelligent artificial climate chamber (12L:12D, H:75%) at a constant temperature of 25° C. Fresh pig lungs were regularly supplied to meet the growth needs of the larvae until they emerged.

[0041] When most larvae were observed to enter the pupal stage, the first sample was collected. At this time, the sample time was recorded as 1-day pupae. 30-50 larvae were randomly sampled each time, frozen in liquid nitrogen and stored in a -80°C refrigerator for subsequent RNA isolation. After that, samples were taken every 24 hours until the pupae emerged into adults. The biological experiment was repeated three times.

[0042] 2. High-throughput sequencing and bioinformatics analysis of Sarcophaga rufipogonidae

[0043] Samples used: The time points for sequencing samples are: 1d pupa (P1), 3d pupa (P2), 5d pupa (P3), 7d pupa (P4), 9d pupa (P5). The biological experiment was repeated three times.

[0044] RNA extraction and library construction and sequencing: According to the instructions of the kit, total RNA in the sample was extracted, DNA was digested, and then mRNA was enriched. Then, the first-strand cDNA and the second-strand cDNA were synthesized, the double-stranded cDNA was purified, the ends were repaired, the sequencing adapters were connected, and PCR amplification was performed. The constructed library was sequenced using the IIIumina HiSeqTM 2500 sequencer to generate 150bp of double-end data.

[0045] Bioinformatics analysis: Trimmomatic software was used to perform quality control on the raw data (raw reads) of sequencing to obtain high-quality clean reads. Then, hisat2 software was used to align the clean reads to the reference genome of the brown-tailed flesh fly (NCBI accession NO.JABZEU000000000). Cuminks software was used to quantify the FPKM expression of genes. Gene function annotation was performed using databases such as GO, KEGG, TrEMBL, Swiss-Prot, and InterPro. The htseq-count software was used to calculate the difference in gene expression, and the nbinomTest function was used to calculate the p-value and fold-change value. Differential genes with a p-value less than 0.05 and a difference fold greater than 2 were screened out, and GO and KEGG enrichment analysis was performed. Through high-throughput sequencing and bioinformatics analysis, the target gene LCP22 (SP_LCP22) sequence with potential application in the control of brown-tailed flesh fly pests was screened for subsequent verification studies.

[0046] 3. Study on RNA interference (dsRNA) of LCP22 gene of Sarcoptes rufipogonidae (SP_LCP22)

[0047] 3.1 The brown-tailed flies were subcultured in the laboratory. Fresh pig lungs were used to induce the brown-tailed flies to lay larvae. The larvae were placed in an intelligent light insect incubator with a photoperiod of 12D:12L, a relative humidity of 75%, and a constant temperature of 25°C. When the larvae were observed to enter the feeding period, 30-50 samples of the feeding period larvae were collected for RNA interference experiments. The biological experiment was repeated three times.

[0048] 3.2 RNA interference experiment. ①d S RNA synthesis and purification: Based on the sequence of the LCP22 gene (SP_LCP22) of the brown-tailed Sarcophaga obtained by sequencing, after cloning and sequencing verification, the primers containing the T7 promoter sequence were designed using the online website E-RNAi (Version 3.2) for in vitro amplification of the template for synthesizing dsRNA. The primers are shown in Table 2. The GFP gene was used as a control group. The dsRNA template with the T7 sequence was synthesized by PCR (the PCR reaction system is shown below). After the reaction was completed, 1% agarose gel electrophoresis was used to detect and separate the target band, and then the agarose gel DNA purification recovery kit was used to recover and purify the target fragment (with the T7 sequence dsRNA template). The detailed information of all relevant primers is listed in "Table 2" for easy reference and verification.

[0049] PCR reaction system

[0050] cDNA template 2μl dsRNA-ForwardPrimer 1μl dsRNA-ReversePrimer 1μl High-FidelityMasterMix 25μl ddH2O 21μl TotalVolume 50μl

[0051] PCR reaction conditions: 94°C pre-denaturation for 3 min, 94°C denaturation for 30 s, 55°C annealing for 30 s, 72°C extension for 1 min, 35 cycles, and 72°C extension for 10 min.

[0052] Using the dsRNA template with T7 sequence synthesized in the previous step, follow the T7 RiboMAX TM The dsRNA synthesis kit of Express RNAiSystem is used to synthesize dsRNA and purify it. The dsRNA synthesis system is as follows:

[0053] <![CDATA[RiboMAX TM Express T7 2X Buffer]]> 10.0μl dsRNA template with T7 sequence (~1μg total) 5.0μl Nuclease-Free Water 3.0μl Enzyme Mix,T7 Express 2.0μl Final Volume 20.0μl

[0054] Operation steps: After mixing, place in a PCR instrument and react at 37°C for 2-6 hours to synthesize dsRNA.

[0055] The synthesized dsRNA was purified according to the kit instructions and stored at -80°C.

[0056] ② dsRNA microinjection: The dsRNA interference method was used to investigate the effect of interfering with the LCP22 gene on the growth and development of the brown-tailed flesh fly. The above 30-50 brown-tailed flesh fly larvae in the feeding stage were selected and dsRNA microinjected using the Nanoject III high-precision microinjector. At the same time, dsGFP was injected as a control group. Each larva was injected with 2μ (4ug) of dsRNA, and the injection site was between the second to last and third abdominal segments of the larvae. Injection of dsGFP was used as a control group.

[0057] ③ Phenotypic observation after RNA interference: After injection, the larvae were placed back in the insect incubator for continued feeding, and observed every 8 hours to record their growth and development, including changes in appearance, pupation time, pupal development time, pupation rate, eclosion rate, etc., until pupation and adult eclosion. 3-5 samples were taken 24h and 48h after dsRNA injection, RNA was extracted, and the interference efficiency of the candidate target gene LCP22 (SP_LCP22) of the brown-tailed fly was detected by SYBR real-time fluorescence quantitative PCR method, as well as the relative expression of metamorphosis-related genes (PCP1, LCP1, LCP2, LCP4), and the actin gene was used as an internal reference gene. At the same time, the independent sample t test (P<0.05) was used for difference significance analysis.

[0058] Table 2 Primer information table described in this patent

[0059]

[0060] Research findings:

[0061] First, we determined the daily developmental expression pattern of the LCP22 gene (SP_LCP22) of the brown-tailed flesh fly during the pupal stage (days 1-9). The results showed that the expression of the SP_LCP22 gene reached a peak in the early pupal stage, and then gradually decreased to a relatively low level before eclosion as the development progressed ( Figure 1 ).

[0062] Figure 2 The differences in biological responses between dsRNA treatment (dsSpLCP22) targeting the LCP22 gene (SP_LCP22) of the brown-tailed flesh fly and the control group (dsGFP) were shown. Compared with the dsGFP control group, the pupation rate after injection of dsSP_LCP22 was reduced to 68%, while the control group was 94%; the eclosion rate was reduced to 28%, while the control group was 76%; the pupal development time was shortened to 240 hours, while the control group was 300 hours ( Figure 2 ). The specific analysis is as follows:

[0063] Figure A: shows the changes in the pupation rate of the dsSpLCP22-treated group and the dsGFP control group over time from the start of the experiment to 60 hours. The results showed that although the pupation rate of both groups increased over time, the pupation rate of the dsSpLCP22-treated group was always lower than that of the dsGFP control group, especially in the late development stage.

[0064] Figure B: The pupation rate at the end of the experiment is summarized in the form of a bar graph. The pupation rate of the dsSpLCP22-treated group was significantly lower than that of the dsGFP control group, with the specific value dropping from 94% to 68% in the control group, showing a statistically significant difference.

[0065] Figure C: depicts the total development time of the two groups of samples during the pupal stage. The development time of the dsSpLCP22-treated group was significantly shorter than that of the dsGFP control group, decreasing from about 300 hours in the control group to about 240 hours, indicating that dsRNA treatment shortened the length of the pupal stage.

[0066] Figure D: shows the comparison of emergence rate. The emergence rate of the dsSpLCP22-treated group was significantly reduced, from 76% of the control group to 28%, showing a very significant statistical difference, which indicates that the interference of the LCP22 gene seriously affected the normal emergence process of the brown-tailed flesh fly.

[0067] Figure 3 The results show in detail the interference efficiency and changes in metamorphosis-related genes at 24 and 48 hours after RNA interference of the LCP22 gene (SP_LCP22) of the brown-tailed fly. We found that compared with the control group dsGFP, the expression level of the target gene SpLCP22 decreased significantly after injection of dsSpLCP22, indicating that this gene was effectively silenced (e.g. Figure 3 ), and real-time quantitative detection of several other metamorphosis-related genes (PCP1, LCP1, LCP2, LCP4) showed that dsSpLCP22 treatment significantly reduced the expression levels of these genes. These results emphasize the important role of the LCP22 gene in the growth and development of the brown-tailed fly, which is of great significance for understanding its function in organisms and potential genetic intervention strategies.

[0068] Phenotypic changes between the dsSpLCP22 group and the dsGFP control group of the brown-tailed Sarcophagus were observed under a stereomicroscope at different developmental stages. Injection of dsSpLCP22 at the late larval stage resulted in pupa deformity, failure to eclosion, rough and asymmetrical pupal shells, deep shrinkage of the pupal segments, stagnation or defects in pupal-adult metamorphosis, and adult wing defects ( Figure 4 ), suggesting that interfering with the LCP22 gene of the brown-tailed flesh fly can affect the metamorphosis of the brown-tailed flesh fly by affecting the structure of the pupal shell, leading to its failure of pupation and emergence.

[0069] The above results show that dsRNA based on the LCP22 gene can effectively kill the brown-tailed fly and significantly reduce the survival rate of the brown-tailed fly, which is of great significance in the prevention and control of the brown-tailed fly.

[0070] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention should be included in the protection scope of the present invention.

Claims

1. A gene fragment of LCP22 of Sarcoptes rufipogonidae, SP_LCP22, It is characterized in that The nucleotide sequence thereof is SEQ ID NO:

1.

2. A dsRNA synthesized based on the SP_LCP22 gene fragment SEQ ID NO: 2 of the brown-tailed Sarcophaga as claimed in claim 1.

3. Use of the dsRNA of the SP_LCP22 gene of the brown-tailed flesh fly as claimed in claim 2 in the control of the brown-tailed flesh fly.

4. Use of the dsRNA of the SP_LCP22 gene of Sarcoptes rufipogonidae as claimed in claim 2 in the control of Sarcoptes rufipogonidae, It is characterized in that The dsRNA is prepared into a sprayable insecticide, or the dsRNA is prepared into a bait, or is directly injected into the body of the brown-tailed fly.